Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Celularity (CELU) Shares Outstanding (Diluted Average) (2021 - 2025)

Celularity has reported Shares Outstanding (Diluted Average) over the past 5 years, most recently at $24.6 million for Q3 2025.

  • Quarterly results put Shares Outstanding (Diluted Average) at $24.6 million for Q3 2025, up 12.15% from a year ago — trailing twelve months through Sep 2025 was $24.6 million (up 12.15% YoY), and the annual figure for FY2024 was $21.9 million, up 22.89%.
  • Shares Outstanding (Diluted Average) for Q3 2025 was $24.6 million at Celularity, up from $23.8 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for CELU hit a ceiling of $151.3 million in Q2 2022 and a floor of $15.5 million in Q1 2023.
  • Median Shares Outstanding (Diluted Average) over the past 5 years was $21.9 million (2024), compared with a mean of $38.2 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): skyrocketed 530.7% in 2022 and later plummeted 88.33% in 2023.
  • Celularity's Shares Outstanding (Diluted Average) stood at $24.0 million in 2021, then skyrocketed by 530.7% to $151.3 million in 2022, then crashed by 88.23% to $17.8 million in 2023, then grew by 22.89% to $21.9 million in 2024, then rose by 12.59% to $24.6 million in 2025.
  • The last three reported values for Shares Outstanding (Diluted Average) were $24.6 million (Q3 2025), $23.8 million (Q2 2025), and $23.5 million (Q1 2025) per Business Quant data.